Glucagon physiology and pathophysiology in the light of new advances
暂无分享,去创建一个
[1] R. Unger,et al. Correction of hyperglycemia with phloridzin restores the glucagon response to glucose in insulin-deficient dogs: implications for human diabetes. , 1985, Proceedings of the National Academy of Sciences of the United States of America.
[2] L. Orci,et al. Adrenergically mediated intrapancreatic control of the glucagon response to glucopenia in the isolated rat pancreas. , 1985, The Journal of clinical investigation.
[3] L. Orci,et al. Insulin within islets is a physiologic glucagon release inhibitor. , 1984, The Journal of clinical investigation.
[4] R. Gabbay,et al. Site of insulin inhibition of cAMP-stimulated glycogenolysis. , 1984, The Journal of biological chemistry.
[5] J. Holst,et al. Circulating glucagon after total pancreatectomy in man , 1983, Diabetologia.
[6] J. McGarry,et al. The metabolic derangements and treatment of diabetic ketoacidosis. , 1983, The New England journal of medicine.
[7] R. Unger. Insulin-Glucagon Relationships in the Defense Against Hypoglycemia , 1983, Diabetes.
[8] L. Orci,et al. New Perspectives on the Microvasculature of the Islets of Langerhans in the Rat , 1982, Diabetes.
[9] T. Claus,et al. Regulation of rat liver fructose 2,6-bisphosphatase. , 1982, The Journal of biological chemistry.
[10] V. Hruby,et al. Hyperglycemia of diabetic rats decreased by a glucagon receptor antagonist. , 1982, Science.
[11] E. Schaftingen,et al. Inactivation of phosphofructokinase 2 by cyclic AMP - dependent protein kinase. , 1981, Biochemical and biophysical research communications.
[12] R. Denton,et al. A partial view of the mechanism of insulin action , 1981, Diabetologia.
[13] K. Uyeda,et al. A novel enzyme catalyzes the synthesis of activation factor from ATP and D-fructose-6-P. , 1981, The Journal of biological chemistry.
[14] K. Uyeda,et al. Regulation of fructose 2,6-P2 concentration in isolated hepatocytes. , 1981, Biochemical and biophysical research communications.
[15] L. Orci,et al. Glucagon and the A cell: physiology and pathophysiology (second of two parts). , 1981, The New England journal of medicine.
[16] O. Owen,et al. Glucagon deficiency and hyperaminoacidemia after total pancreatectomy. , 1980, The Journal of clinical investigation.
[17] J. McGarry,et al. The role of malonyl-coa in the coordination of fatty acid synthesis and oxidation in isolated rat hepatocytes. , 1978, The Journal of biological chemistry.
[18] K. Kim,et al. Regulation of rat liver acetyl-CoA carboxylase. Stimulation of phosphorylation and subsequent inactivation of liver acetyl-CoA carboxylase by cyclic 3':5'-monophosphate and effect on the structure of the enzyme. , 1978, The Journal of biological chemistry.
[19] P. Lefèbvre,et al. Glucose and insulin in the regulation of glucagon release from the isolated perfused dog stomach. , 1978, Endocrinology.
[20] A. Cherrington,et al. Effect of glucagon on glucose production during insulin deficiency in the dog. , 1978, The Journal of clinical investigation.
[21] J. McGarry,et al. Carnitine palmitoyltransferase I. The site of inhibition of hepatic fatty acid oxidation by malonyl-CoA. , 1978, The Journal of biological chemistry.
[22] R. Unger,et al. The role of glucagon deficiency in the Houssay phenomenon of dogs. , 1978, The Journal of clinical investigation.
[23] R. C. Nielsen,et al. Effect of glucagon on hepatic malonyl coenzyme A concentration and on lipid synthesis. , 1977, The Journal of biological chemistry.
[24] L. Orci,et al. Gastric A-cell function in insulin-deprived depancreatized dogs. , 1976, Endocrinology.
[25] M. Lorenzi,et al. Comparison of the suppressive effects of elevated plasma glucose and free fatty acid levels on glucagon secretion in normal and insulin-dependent diabetic subjects. Evidence for selective alpha-cell insensitivity to glucose in diabetes mellitus. , 1976, The Journal of clinical investigation.
[26] P. Raskin,et al. Effect of Insulin on the Exaggerated Glucagon Response to Arginine Stimulation in Diabetes Mellitus , 1976, Diabetes.
[27] S. Bloom,et al. PANCREATECTOMISED MAN: A MODEL FOR DIABETES WITHOUT GLUCAGON , 1976, The Lancet.
[28] J. McGarry,et al. Role of carnitine in hepatic ketogenesis. , 1975, Proceedings of the National Academy of Sciences of the United States of America.
[29] E. Tsalikian,et al. Prevention of human diabetic ketoacidosis by somatostatin. Evidence for an essential role of glucagon. , 1975, The New England journal of medicine.
[30] L. Orci,et al. Glucagon: role in the hyperglycemia of diabetes mellitus. , 1975, Science.
[31] L. Orci,et al. THE ESSENTIAL ROLE OF GLUCAGON IN THE PATHOGENESIS OF DIABETES MELLITUS , 1975, The Lancet.
[32] R. Unger,et al. The effect of insulin on the alpha-cell response to hyperglycemia in long-standing alloxan diabetes. , 1974, The Journal of clinical investigation.
[33] P. Jonescu. Letter: Herpes simplex encephalitis. , 1974, Lancet.
[34] K. Taylor,et al. Oxidation of glucose and fatty acids in normal and in A2-cell rich pancreatic islets isolated from guinea-pigs , 1972, Diabetologia.
[35] L. Frohman,et al. Effect of hypothalamic stimulation on plasma glucose, insulin, and glucagon levels. , 1971, The American journal of physiology.
[36] J. R-Candela. GLUCAGON AND INSULIN SECRETION , 1966 .
[37] R. Unger. The milieu interieur and the islets of Langerhans , 2004, Diabetologia.
[38] W. Stalmans. Glucagon and Liver Glycogen Metabolism , 1983 .
[39] M. Massi-Benedetti,et al. Glucagon and carbohydrate disorder in a totally pancreatectomized man (A study with the aid of an artificial endocrine pancreas) , 1981, Journal of endocrinological investigation.
[40] R. Unger. The milieu interieur and the islets of Langerhans , 1981 .
[41] J. McGarry,et al. Regulation of hepatic fatty acid oxidation and ketone body production. , 1980, Annual review of biochemistry.
[42] G WhittakerP,et al. 共やくエクイン・エストロゲン(Premarin)服用閉経婦人の血清エクイリン,エストロン,エストラジオール値 , 1980 .
[43] P. Bouman,et al. IS PHENYLALANINE SUPERIOR TO LEUCINE AS LABELED SUBSTRATE FOR INSULIN-BIOSYNTHESIS IN RAT PANCREATIC-ISLETS , 1978 .